Basic Information
| RNALocate ID: | RLID:01002023 |
| RNA Symbol: | hsa-miR-365a-3p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-365 |
| RNA ID: | miRBase:MIMAT0000710 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 20498841 |
| Tissue/Cell Line: | Nasopharyngeal carcinoma cells |
| Method: | Next-generation RNA sequencing |
| Description: | The expression level of all microRNAs that detected in the nuclear and cytoplasmic 18-30nt sRNA of 293T cell line. Table S5. The N/C values of all isomiRs. The isomiRs are shown only if it displayed a raw read count (non-normalized) more than 10 in at least one library. Data are collected from Table S5, S9. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002024 | Mitochondrion | Myotube | 27396686 |
| RLID:01002025 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002026 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002442 | Exosome | Serum | 18589210 |
| RLID:11002443 | Exosome | Brain tissue | 23382797 |
| RLID:11002444 | Exosome | Plasma | 23663360 |
| RLID:11002445 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002446 | Exosome | Serum | 24683445 |
| RLID:11002447 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11002448 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID-D:11000119 | Exosome | Breast milk | |
| RLID-D:11000409 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-365a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-44188 |
| MNDR | hsa-miR-365a-3p | Oral squamous cell carcinoma | MNDR-E-MI-44189 |
| MNDR | hsa-miR-365a-3p | Medulloblastoma | MNDR-E-MI-44190 |
| MNDR | hsa-miR-365a-3p | Lymphoma | MNDR-E-MI-44191 |
| MNDR | hsa-miR-365a-3p | Niemann-pick disease type c | MNDR-E-MI-44192 |
| MNDR | hsa-miR-365a-3p | Lupus nephritis | MNDR-E-MI-44193 |
| MNDR | hsa-miR-365a-3p | Polycystic kidney diseases | MNDR-E-MI-44194 |
| MNDR | hsa-miR-365a-3p | Dermatomyositis | MNDR-E-MI-44195 |
| MNDR | hsa-miR-365a-3p | Prostate cancer | MNDR-E-MI-44196 |
| MNDR | hsa-miR-365a-3p | Gastric cancer | MNDR-E-MI-44197 |
| MNDR | hsa-miR-365a-3p | Alzheimer disease | MNDR-E-MI-44198 |
| MNDR | hsa-miR-365a-3p | Intracranial aneurysm | MNDR-E-MI-44199 |
| MNDR | hsa-miR-365a-3p | Bladder cancer | MNDR-E-MI-44200 |
| MNDR | hsa-miR-365a-3p | Esophageal carcinoma | MNDR-E-MI-44201 |
| MNDR | hsa-miR-365a-3p | Dysautonomia familial | MNDR-E-MI-44202 |
| MNDR | hsa-miR-365a-3p | Polycystic ovary syndrome | MNDR-E-MI-44203 |
| MNDR | hsa-miR-365a-3p | Myotonic dystrophy | MNDR-E-MI-44204 |
| MNDR | hsa-miR-365a-3p | Cardiovascular disease | MNDR-E-MI-44205 |
| MNDR | hsa-miR-365a-3p | Lung cancer | MNDR-E-MI-44206 |
| MNDR | hsa-miR-365a-3p | Eosinophilic esophagitis | MNDR-E-MI-44207 |
| MNDR | hsa-miR-365a-3p | Parkinson disease | MNDR-E-MI-44208 |
| MNDR | hsa-miR-365a-3p | Niemann-pick disease | MNDR-E-MI-44209 |
| MNDR | hsa-miR-365a-3p | Basal-like breast cancer | MNDR-E-MI-44210 |
| MNDR | hsa-miR-365a-3p | Neuroendocrine neoplasia | MNDR-E-MI-44211 |
| MNDR | hsa-miR-365a-3p | Squamous cell carcinoma | MNDR-E-MI-44212 |
| MNDR | hsa-miR-365a-3p | Vascular diseases | MNDR-E-MI-44213 |
| MNDR | hsa-miR-365a-3p | Pituitary neoplasms | MNDR-E-MI-44214 |
| MNDR | hsa-miR-365a-3p | Pancreatic cancer | MNDR-E-MI-44215 |
| MNDR | hsa-miR-365a-3p | Melanoma | MNDR-E-MI-44216 |
| MNDR | hsa-miR-365a-3p | Rectum adenocarcinoma | MNDR-E-MI-44217 |
| MNDR | hsa-miR-365a-3p | Nephroblastoma | MNDR-E-MI-44218 |
| MNDR | hsa-miR-365a-3p | Colon cancer | MNDR-E-MI-44219 |
| MNDR | hsa-miR-365a-3p | Colon adenocarcinoma | MNDR-E-MI-44220 |
| MNDR | hsa-miR-365a-3p | Multiple sclerosis | MNDR-E-MI-44221 |
| MNDR | hsa-miR-365a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-44222 |
| MNDR | hsa-miR-365a-3p | Acromegaly | MNDR-E-MI-44223 |
| MNDR | hsa-miR-365a-3p | Prostate adenocarcinoma | MNDR-E-MI-44224 |
| MNDR | hsa-miR-365a-3p | Laryngeal squamous cell carcinoma | MNDR-E-MI-44225 |
| MNDR | hsa-miR-365a-3p | Endometriosis | MNDR-E-MI-44226 |
| MNDR | hsa-miR-365a-3p | Carcinoma ductal breast | MNDR-E-MI-44227 |
| MNDR | hsa-miR-365a-3p | Glioblastoma | MNDR-E-MI-44228 |
| MNDR | hsa-miR-365a-3p | Glioma | MNDR-E-MI-44229 |
| MNDR | hsa-miR-365a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-44230 |
| MNDR | hsa-miR-365a-3p | Osteosarcoma | MNDR-E-MI-44231 |
| MNDR | hsa-miR-365a-3p | Liposarcoma | MNDR-E-MI-44232 |
| MNDR | hsa-miR-365a-3p | Inclusion body myositis | MNDR-E-MI-44233 |
| MNDR | hsa-miR-365a-3p | Breast carcinoma | MNDR-E-MI-44234 |
| MNDR | hsa-miR-365a-3p | Liver cancer | MNDR-E-MI-44235 |
| MNDR | hsa-miR-365a-3p | Cervical adenocarcinoma | MNDR-E-MI-44236 |
| MNDR | hsa-miR-365a-3p | Gastric adenocarcinoma | MNDR-E-MI-44237 |
| MNDR | hsa-miR-365a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-44238 |
| MNDR | hsa-miR-365a-3p | Pituitary adenoma | MNDR-E-MI-44239 |
| MNDR | hsa-miR-365a-3p | Lung squamous cell carcinoma | MNDR-E-MI-44240 |
| MNDR | hsa-mir-365a-3p | Lung adenocarcinoma | MNDR-E-MI-44241 |
| MNDR | hsa-miR-365a-3p | Thyroid carcinoma | MNDR-E-MI-44242 |
| MNDR | hsa-miR-365a-3p | Bladder urothelial carcinoma | MNDR-E-MI-44243 |
| MNDR | hsa-miR-365a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-44244 |
| MNDR | hsa-miR-365a-3p | Carcinoma renal cell | MNDR-E-MI-44245 |
| MNDR | hsa-miR-365a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-44246 |
| MNDR | hsa-miR-365a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-44247 |
| MNDR | hsa-miR-365a-3p | Cholangiocarcinoma | MNDR-E-MI-44248 |
| MNDR | hsa-miR-365a-3p | Esophageal cancer | MNDR-E-MI-44249 |
| MNDR | hsa-miR-365a-3p | Oncocytoma | MNDR-E-MI-44250 |
| MNDR | hsa-miR-365a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-44251 |
| MNDR | hsa-miR-365a-3p | Heart failure | MNDR-E-MI-44252 |
| MNDR | hsa-miR-365a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-44253 |
| MNDR | hsa-miR-365a-3p | Breast invasive carcinoma | MNDR-E-MI-44254 |
| MNDR | hsa-miR-365a-3p | Hepatocellular carcinoma | MNDR-E-MI-44255 |
| MNDR | hsa-miR-365a-3p | B-cell lymphoma | MNDR-E-MI-44256 |
| MNDR | hsa-miR-365a-3p | Barrett's adenocarcinoma | MNDR-E-MI-44257 |
| MNDR | hsa-miR-365a-3p | Hodgkin lymphoma | MNDR-E-MI-44258 |
| MNDR | hsa-miR-365a-3p | Psoriasis | MNDR-E-MI-44259 |
| MNDR | hsa-miR-365a-3p | Skin cutaneous melanoma | MNDR-E-MI-44260 |
| MNDR | hsa-miR-365a-3p | Skin melanoma | MNDR-E-MI-44261 |
| MNDR | hsa-miR-365a-3p | Colorectal cancer | MNDR-E-MI-44262 |
| MNDR | hsa-miR-365a-3p | Nasopharynx carcinoma | MNDR-E-MI-44263 |
| MNDR | hsa-miR-365a-3p | Multiple myeloma | MNDR-E-MI-44264 |
| MNDR | hsa-miR-365a-3p | Lupus vulgaris | MNDR-E-MI-44265 |
| MNDR | hsa-miR-365a-3p | Nasopharyngeal cancer | MNDR-E-MI-44266 |
| MNDR | hsa-miR-365a-3p | Pseudorabies | MNDR-E-MI-44267 |
| MNDR | hsa-miR-365a-3p | Epstein-barr virus infections | MNDR-E-MI-44268 |
| MNDR | hsa-miR-365a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-44269 |
| MNDR | hsa-miR-365a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-44270 |
| MNDR | hsa-miR-365a-3p | Barrett's carcinogenesis | MNDR-E-MI-44271 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1 | Homo sapiens | RR00038778 |
TOP